BOPA response to the report of the UK Commission on Pharmacy Professional Leadership

BOPA welcomes publication of the report of the UK Commission on Pharmacy Professional Leadership, with its focus on the future of the pharmacy profession. BOPA shares the ambitions outlined within this report and the vision for a model of leadership which supports greater collaboration between established professional leadership groups. While we are disappointed to not have been consulted as part of the initial stakeholder engagement, we are pleased that this report acknowledges the significant contribution of pharmacy professional leadership groups, including BOPA, to support pharmacy professionals to meet the challenges of delivering exceptional care to patients.

This publication makes a number of significant recommendations, which are likely to have a substantial impact on the future of the pharmacy profession. BOPA is committed to representing the views of its members and representing their interests in all of our undertakings. We would encourage all BOPA members to carefully consider the contents and recommendations outlined within this report.

BOPA is working closely with the UK Commission on Pharmacy Professional Leadership, and the UK Chief Pharmaceutical Officers, to develop a model which is inclusive of the range of professional leaderships bodies and which best represents the interests of all pharmacy professionals.

The BOPA Executive Committee

 

 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article